Viewing Study NCT05511064



Ignite Creation Date: 2024-05-06 @ 6:01 PM
Last Modification Date: 2024-10-26 @ 2:39 PM
Study NCT ID: NCT05511064
Status: RECRUITING
Last Update Posted: 2023-05-01
First Post: 2022-08-19

Brief Title: CEFID-II CEra Flow Improves DVT-II
Sponsor: Ceragem Clinical Inc
Organization: Ceragem Inc

Study Overview

Official Title: A Multiple Center Clinical Trial to Evaluate the Efficacy and Safety of Blood Circulation Improvement Using an Investigational Device Model Name CGM MB-1701 for the Risk Group of Deep Vein Thrombosis DVT
Status: RECRUITING
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: For Deep Vein Thrombosis DVT risk groups the effect and safety of blood circulation improvement before and after application are evaluated using an investigational device model name CGM MB-1701
Detailed Description: The investigator applies the test device to the appropriate subjects for a total of 10 days 1 days at the institution and nursing hospital and upon discharge for long-term follow-up investigation the investigational device is applied at subjects home according to the subjects consent for about 3 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None